Breast cancer PET/CT imaging with a new tracer
Part of Cancer, Skin clinical trials.
This trial tests a new imaging agent (68Ga-pAKTi) that may help doctors see breast cancer cells with a PET/CT scan. It is for people with a specific genetic change in their tumor, and who have not yet had surgery to remove the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have breast cancer, or imaging tests strongly suggest it.
- You have not had surgery to remove the tumor.
- You have had a special test that found a change in your tumor's PIK3CA gene, PTEN gene, or a related pathway (PI3K-AKT-mTOR).
- You are able to lie still for about 30 minutes during a PET/CT scan.
- You agree to use birth control for at least 28 days after the scan (if you or your partner could become pregnant).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging agent that may help doctors see tumors more clearly during a PET scan. It could help diagnose cancer or check if it has returned after treatment.
This trial uses a special PET/CT scan that targets a protein on some cancer cells to help detect and evaluate malignant tumors. It may help doctors better map tumors before any cancer treatment starts.
This study tests whether a new type of PET/MRI scan can help doctors see how well breast cancer treatment is working. It is a platform study, meaning it can evaluate different treatments, but the focus is on using this advanced imaging to monitor response.
This trial uses a special PET/CT scan to find breast cancer cells that have a certain marker (CD73). It may help doctors see the cancer more clearly before you start other treatments.
This study tests a new imaging agent (18F-FAPI-04) for PET scans to see if it can better detect breast cancer or its spread. It may help doctors find tumors more clearly.
This study tests a new imaging agent that helps PET scans show cancer more clearly. It may help doctors see where cancer is in your body and plan your treatment better.
Hear when a new PET/CT trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.